Dynamics of morphological changes of platelet granules in patients with hypertension and high cardiovascular risk in applying losartan potassium.

Authors

  • I. V. Tverdokhleb ДЗ «Дніпропетровська медична академія МОЗ України», Ukraine
  • N. O. Pertseva ДЗ «Дніпропетровська медична академія МОЗ України», Ukraine
  • T. S. Turliun ДЗ «Дніпропетровська медична академія МОЗ України», Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2014.2.61-66

Keywords:

hypertension, diabetes mellitus type 2, platelet granules, ultrastructure, losartan

Abstract

Background. Disorders of hemostasis in patients with arterial hypertension and diabetes mellitus type 2 are complex: growing aggregative activity of platelets and red blood cells, activation and degranulation of platelet antiaggregatory potential endothelium; reduced anticoagulant and fibrinolytic activity of blood. Objective. Quantification of ultrastructural changes in different types of platelet granules in patients with hypertension with high cardiovascular risk influenced the treatment losartan potassium. Methods. Ultrastructural studies of platelet granules was performed in 5 patients with hypertension 2nd degree (first clinical group), 10 patients with hypertension (second group) of degree 2 with type 2 diabetes in the stage subcompensation and 5 volunteers – healthy individuals (control group). To correct blood pressure was used angiotensin II receptor antagonist losartan (Lozap®, Zentiva). Ultrastructural analysis was performed at baseline and at 3, 6, 9 and 12 months of treatment. Results. For a detailed analysis of the process of activation and degranulation of platelets using transmission electron microscopy was carried out differential counting packing density of alpha and delta granules consisting hranulomera and numerical density lambda granules. Conclusion. In patients with hypertension namely platelet aggregation capacity was the most sensitive element of damage platelet hemostasis, which could largely normalized since 6-month use of losartan potassium. In the group of patients with hypertension and diabetes mellitus type 2, in which the initial contents dehranulated platelets was sharply increased, there was a significant positive trend for treatment involving losartan, which indicates its significant contribution to achieving normalization of dehranulated forms. Treatment with losartan potassium leads to a significant recovery of alpha-granules, normalize the content of dense bodyes and limitations of lysosomal activity in all groups.

References

  1. Shilov AM. Gipertenziya i reologiya krovi [Hypertension and blood rheology]. Moscow: BARS; 2005. 328 p. Russian.
  2. Blair P. Platelet α-granules: Basic biology and clinical correlates. Blood Rev. 2009;23(4):177-89.
  3. Woodman PG, Futter CE. Multivesicular bodies: coordinated progression to maturity. Curr Opin Cell Biol. 2008;20:408-14.
  4. White JC, Clawson CC. The surface-connected canalicular system of blood platelets-a fenestrated membrane system. Am J Pathol. 1980;101:353-64.
  5. Frojmovic MM, Milton JG. Human platelet size, shape, and related functions in health and disease. Physiol Rev. 1982;62:185-261.
  6. Sehgal S, Storrie B. Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release. J Thromb Haemost. 2007;5:2009-16.
  7. Italiano JE, Richardson JL, Patel-Hett S. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha-granules and differentially released. Blood. 2008;111:1227-33.
  8. Vaskina EA, Tsirendorzhiev DD, Demina LM. Rol neytrofilov i prooksidantnogo potentsiala krovi v razvitii endotelialnoy disfunktsii pri arterialnoy gipertenzii [Role of neutrophils and pro-oxidant capacity of the blood in the development of endothelial dysfunction in hypertension]. Bulletin SO RAMN. 2003;2:107-12. Russian.
  9. Medvedev IV, Kumova TA. Oslablenie agregatsionnoy sposobnosti trombotsitov u bolnyih arterialnoy gipertoniey pri metabolicheskom sindrome na fone lozartana. [Weakening aggregability platelets in hypertensive patients with metabolic syndrome on a background of losartan]. Russ J Cardiol. 2008;5:53-5. Russian.
  10. Sawatzke CL, Solomons CC. Fixation and embedding of small volumes of platelets for transmission electron microscopy. J Clin Pathol. 1980;33(6):600-2.
  11. Mironov AA, Komissarchik YuYa, Mironov VA. Metodyi elektronnoy mikroskopii v biologii i meditsine: Metodicheskoe rukovodstvo. [Electron microscopy methods in biology and medicine : Methodological Guide]. St. Petersburg: Science; 1994. 400 p. Russian.

Downloads

How to Cite

Tverdokhleb, I. V., Pertseva, N. O., & Turliun, T. S. (2014). Dynamics of morphological changes of platelet granules in patients with hypertension and high cardiovascular risk in applying losartan potassium. Морфологія / Morphologia / Morfologìâ, 8(2), 61–66. https://doi.org/10.26641/1997-9665.2014.2.61-66

Issue

Vol. 8 No. 2 (2014)

Section

Статті

License

Copyright (c) 2018 Morphologia

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.
        By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world. 
        The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.